Cohance Lifesciences Limited (NSE:COHANCE)
India flag India · Delayed Price · Currency is INR
1,079.20
+21.00 (1.98%)
At close: May 16, 2025
66.45%
Market Cap 274.73B
Revenue (ttm) 10.48B
Net Income (ttm) 2.79B
Shares Out 254.56M
EPS (ttm) 10.93
PE Ratio 98.71
Forward PE 59.48
Dividend n/a
Ex-Dividend Date n/a
Volume 1,177,218
Average Volume 244,996
Open 1,060.00
Previous Close 1,058.20
Day's Range 1,051.00 - 1,090.00
52-Week Range 598.00 - 1,360.00
Beta 1.13
RSI 43.70
Earnings Date May 28, 2025

About Cohance Lifesciences

Cohance Lifesciences Limited engage in the end-to-end contract development and manufacturing of intermediates and active pharmaceutical ingredients in India. The coampny offers active pharmaceutical ingredients and formulations for various applications; CDMO services, a flexible and custom solutions for challenging development and manufacturing needs; and clinical, analytical, and research services. It also manufactures finished dosage formulations for pharmaceutical companies; and specialty chemicals, such as electronic chemicals. The company ... [Read more]

Industry Pharmaceutical Preparations
Founded 1989
Employees 1,193
Stock Exchange National Stock Exchange of India
Ticker Symbol COHANCE
Full Company Profile

Financial Performance

In 2023, Cohance Lifesciences's revenue was 10.51 billion, a decrease of -21.56% compared to the previous year's 13.40 billion. Earnings were 3.00 billion, a decrease of -26.99%.

Financial Statements

News

There is no news available yet.